Clinical trial
Prednisone Plus Chloroquine Versus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly in Papua New Guinea: a Randomized Open-label Trial
NCT01785979 is registered in ClinicalTrials.gov with Lihir Medical Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prednisone Plus Chloroquine Versus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly in Papua New Guinea: a Randomized Open-label Trial
- Lead sponsor
- Lihir Medical Centre
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- January 31, 2016
- Completion date
- February 28, 2017
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anaemia, hyper-reactive malarial splenomegaly, malaria